Tech Company Financing Transactions

Protai Funding Round

Grove Ventures, Maj Invest and Pitango Venture Capital joined a $12 million Seed capital raise for Protai. The round was announced on 3/15/2023.

Transaction Overview

Company Name
Announced On
3/15/2023
Transaction Type
Venture Equity
Amount
$12,000,000
Round
Seed
Investors

Grove Ventures (Lead Investor) (Lior Handelsman)

Maj Invest

Pitango Venture Capital (Ittai Harel)

Proceeds Purpose
The company intends to use the funds to build its oncology drug discovery pipeline, expand data acquisition, as well as increase its discovery activities via pharma partnerships.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
4 Boáz Ramat Gan
Tel Aviv, 5320047
Israel
Phone
Undisclosed
Email Address
Overview
We are an AI-powered drug discovery startup that is revolutionizing the way new drugs can be discovered. We combine deep proteomics with machine learning to better combat complex diseases and create a healthier world.
Profile
Protai LinkedIn Company Profile
Social Media
Protai Company Twitter Account
Company News
Protai News
Facebook
Protai on Facebook
YouTube
Protai on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Eran Seger
  Eran Seger LinkedIn Profile  Eran Seger Twitter Account  Eran Seger News  Eran Seger on Facebook
Chief Technical Officer
Kirill Pevzner
  Kirill Pevzner LinkedIn Profile  Kirill Pevzner Twitter Account  Kirill Pevzner News  Kirill Pevzner on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/14/2023: Upduo venture capital transaction
Next: 3/15/2023: Genpop Interactive venture capital transaction

 

Share this article

 


News on VC Transactions

We do our best to report on every notable VC transaction. VC transactions on this site are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary